R132H IDH1 sensitizes glioma to the antiproliferative and cytotoxic effects of BET inhibition.

and is associated with greater sensitivity to BET inhibition. The finding that BET inhibition primarily exhibits delayed cytotoxicity may be overlooked in conventional short endpoint dose-response assays. Follow-up mechanistic and animal studies will help address the translational potential of these findings.